Acute myeloid leukaemia with myelodysplasia-related changes (Q39190): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Leucemia mieloide aguda com pelo menos 20% de blastos na medula óssea ou no sangue com história anterior de síndrome mielodisplásica, displasia multilinhagem ou anormalidades citogenéticas típicas relacionadas à síndrome mielodisplásica. Não há história de terapia citotóxica anterior para um distúrbio não relacionado, e há ausência das anormalidades genéticas que estão presentes na leucemia mieloide aguda com anormalidades genéticas recorrentes. | |||
| description / en | description / en | ||
An acute myeloid leukaemia with at least 20% blasts in the bone marrow or blood, and either a previous history of myelodysplastic syndrome, multilineage dysplasia or typical myelodysplastic syndrome-related cytogenetic abnormalities. There is no history of prior cytotoxic therapy for an unrelated disorder, and there is absence of the genetic abnormalities that are present in acute myeloid leukaemia with recurrent genetic abnormalities. | |||
Revision as of 04:31, 13 August 2026
An acute myeloid leukaemia with at least 20% blasts in the bone marrow or blood, and either a previous history of myelodysplastic syndrome, multilineage dysplasia or typical myelodysplastic syndrome-related cytogenetic abnormalities. There is no history of prior cytotoxic therapy for an unrelated disorder, and there is absence of the genetic abnormalities that are present in acute myeloid leukaemia with recurrent genetic abnormalities.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A60.1 |
||
| English | Acute myeloid leukaemia with myelodysplasia-related changes |
An acute myeloid leukaemia with at least 20% blasts in the bone marrow or blood, and either a previous history of myelodysplastic syndrome, multilineage dysplasia or typical myelodysplastic syndrome-related cytogenetic abnormalities. There is no history of prior cytotoxic therapy for an unrelated disorder, and there is absence of the genetic abnormalities that are present in acute myeloid leukaemia with recurrent genetic abnormalities. |
